Acorda Therapeutics, Inc.
OTC: ACORQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ron Cohen
- Employees
- 102
- Headquarters
- Pearl River, United States
- IPO year
- 2006
- Market cap
- $12.4K
- Website
- https://www.acorda.com
Loading ACORQ…
Loading profile data…Frequently asked questions about ACORQ
What does Acorda Therapeutics, Inc. (ACORQ) do?
Acorda Therapeutics, Inc. operates as a biopharmaceutical enterprise focused on researching, developing, and bringing to market medical treatments for neurological conditions, predominantly in the United States. The company offers Ampyra (dalfampridine), an oral medication aimed at enhancing walking capabilities in adult patients experiencing mu...
Where does ACORQ trade?
Acorda Therapeutics, Inc. (ACORQ) trades on the Other OTC.
What sector is ACORQ in?
Acorda Therapeutics, Inc. (ACORQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Acorda Therapeutics, Inc.?
Ron Cohen is the chief executive officer of Acorda Therapeutics, Inc. (ACORQ).
Where is Acorda Therapeutics, Inc. headquartered?
Acorda Therapeutics, Inc. is headquartered in United States.
Does ACORQ pay a dividend?
Acorda Therapeutics, Inc. (ACORQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACORQ go public?
Acorda Therapeutics, Inc. (ACORQ) completed its initial public offering in 2006.